Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -58.65x is 46% above its 4-year average of -109.10x, near the high end of its 4-year range (-173.36x–-34.69x).
27.07% above its 12-month average of -80.42x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -173.36x.
INTEREST COVERAGE RATIO
-58.65x
INTEREST COVERAGE RATIO AVG TTM
-80.42x
INTEREST COVERAGE RATIO AVG 3Y
-104.54x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+27.07%
CURRENT VS 3Y AVG
+43.90%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-912.95%
vs the sector median at left
Pliant Therapeutics, Inc.
Market Cap
$63.78M
Interest Coverage Ratio
-58.65x
TTM Avg
-80.42x
3Y Avg
-104.54x
5Y Avg
N/A
Market Cap
$64.06M
Interest Coverage Ratio
-66.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.15M
Interest Coverage Ratio
0.34x
TTM Avg
0.34x
3Y Avg
1.90x
5Y Avg
3.13x
Market Cap
$64.58M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.02M
Interest Coverage Ratio
-14.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$61.12M
Interest Coverage Ratio
-31.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.85M
Interest Coverage Ratio
-632.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.46M
Interest Coverage Ratio
-21.57x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pliant Therapeutics, Inc. (PLRX) | $63.78M | -58.65x | -80.42x | -104.54x | N/A |
| Alps Group Inc (ALPS)vs › | $64.06M | -66.90x | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $65.15M | 0.34x | 0.34x | 1.90x | 3.13x |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.58M | N/A | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $64.88M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.02M | -14.86x | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.12M | -31.98x | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | -632.78x | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.46M | -21.57x | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.48M | -3392.06x | 18.65x | 15.79x | 19.13x |
Interest Coverage
-58.6x
Debt/Equity
0.20
Current Ratio
9.90
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -173.36x |
| 2025-09-30 | -34.69x |
| 2025-06-30 | -56.36x |
| 2025-03-31 | -73.76x |
| 2024-12-31 | -63.93x |
| 2024-09-30 | -70.71x |
| 2024-06-30 | -69.86x |
| 2024-03-31 | -117.73x |
| 2023-12-31 | -146.53x |
| 2023-09-30 | -150.43x |
| 2023-06-30 | -148.36x |
| 2023-03-31 | -135.35x |
| 2022-12-31 | -117.98x |
| 2022-09-30 | -106.14x |
| 2022-06-30 | -171.34x |
